Bliss GVS Pharma Ltd

NSE: BLISSGVS · BSE: 506197 · Pharmaceuticals & Biotechnology · 40 announcements

Share price: ₹680.00
Market cap: ₹7,230 Cr
Revenue (annual): ₹927.1 Cr
Net profit (annual): ₹129.1 Cr
P/E (TTM): 53.1×Sector 47.4×
Promoter holding: 35.01%-0.35% QoQ
FII holding: 8.07%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

Announcement type

All Open Offer 7 Employee Stock Options 7 Annual General Meeting 6 Management Change 4 Other Announcement 3 Financial Results 3 Board Meeting Date 3 Promoter Selling 2 Capital Structure Change 2 Credit Rating 1 Business Update 1 Acquisition 1

Time

All time Last 1 week Last 1 month Last 2 months Last 3 months Last 6 months Last 1 year

1 announcement with these filters

2 Jun 2026 19:28 IST BSE

Business Update

Bliss GVS Pharma Business Update

Bliss GVS Pharma received a WHO-GMP Inspection Closure Report for its Palghar manufacturing facility. This certification confirms compliance with international quality standards for pharmaceutical manufacturing.

Read the filing ↗